{"title":"抗pf4抗体通过诱导细胞凋亡和细胞周期阻滞抑制无TP53突变的肺癌细胞增殖","authors":"Mengjia Qian, Zhihui Min, Yanxia Zhan, Lili Ji, Bijun Zhu, Miaomiao Zhang, Qi Shen, Pengcheng Xu, Hao Chen, Yunfeng Cheng","doi":"10.1002/ctd2.70075","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Elevated platelet count is correlated with poor survival of lung cancer. Platelet factor 4 (PF4), a platelet-specific protein, plays an important role in platelet function. Emerging evidence suggests that regulation of PF4 can modulate platelet function to impact the progression of lung cancer.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Anti-PF4 antibody was used to neutralise PF4 to regulate platelet function in the co-culture of platelets and lung cancer cells lines of H1299 and A549. The proliferation, apoptosis and cell cycle were examined by cell counting kit-8 (CCK-8) test and flow cytometry.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Anti-PF4 antibody inhibited the proliferation of H1299 and A549 cells when stimulated with platelets, yet induced cell cycle arrest and cell apoptosis only in A549, not H1299. The proliferation, cell cycle distribution and apoptosis were not affected by anti-PF4 antibody in A549<sup>TP53‒</sup> cells.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Anti-PF4 antibody exerted anti-proliferative effects by inducing apoptosis and cell cycle arrest in lung cancer cells without TP53 mutation via p53 signalling pathway when stimulated with platelets.</p>\n </section>\n </div>","PeriodicalId":72605,"journal":{"name":"Clinical and translational discovery","volume":"5 4","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctd2.70075","citationCount":"0","resultStr":"{\"title\":\"Anti-PF4 antibody inhibit proliferation of lung cancer cells without TP53 mutation by inducing apoptosis and cell cycle arrest\",\"authors\":\"Mengjia Qian, Zhihui Min, Yanxia Zhan, Lili Ji, Bijun Zhu, Miaomiao Zhang, Qi Shen, Pengcheng Xu, Hao Chen, Yunfeng Cheng\",\"doi\":\"10.1002/ctd2.70075\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Elevated platelet count is correlated with poor survival of lung cancer. Platelet factor 4 (PF4), a platelet-specific protein, plays an important role in platelet function. Emerging evidence suggests that regulation of PF4 can modulate platelet function to impact the progression of lung cancer.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Anti-PF4 antibody was used to neutralise PF4 to regulate platelet function in the co-culture of platelets and lung cancer cells lines of H1299 and A549. The proliferation, apoptosis and cell cycle were examined by cell counting kit-8 (CCK-8) test and flow cytometry.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Anti-PF4 antibody inhibited the proliferation of H1299 and A549 cells when stimulated with platelets, yet induced cell cycle arrest and cell apoptosis only in A549, not H1299. The proliferation, cell cycle distribution and apoptosis were not affected by anti-PF4 antibody in A549<sup>TP53‒</sup> cells.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Anti-PF4 antibody exerted anti-proliferative effects by inducing apoptosis and cell cycle arrest in lung cancer cells without TP53 mutation via p53 signalling pathway when stimulated with platelets.</p>\\n </section>\\n </div>\",\"PeriodicalId\":72605,\"journal\":{\"name\":\"Clinical and translational discovery\",\"volume\":\"5 4\",\"pages\":\"\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-07-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ctd2.70075\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and translational discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ctd2.70075\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and translational discovery","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ctd2.70075","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Anti-PF4 antibody inhibit proliferation of lung cancer cells without TP53 mutation by inducing apoptosis and cell cycle arrest
Background
Elevated platelet count is correlated with poor survival of lung cancer. Platelet factor 4 (PF4), a platelet-specific protein, plays an important role in platelet function. Emerging evidence suggests that regulation of PF4 can modulate platelet function to impact the progression of lung cancer.
Methods
Anti-PF4 antibody was used to neutralise PF4 to regulate platelet function in the co-culture of platelets and lung cancer cells lines of H1299 and A549. The proliferation, apoptosis and cell cycle were examined by cell counting kit-8 (CCK-8) test and flow cytometry.
Results
Anti-PF4 antibody inhibited the proliferation of H1299 and A549 cells when stimulated with platelets, yet induced cell cycle arrest and cell apoptosis only in A549, not H1299. The proliferation, cell cycle distribution and apoptosis were not affected by anti-PF4 antibody in A549TP53‒ cells.
Conclusion
Anti-PF4 antibody exerted anti-proliferative effects by inducing apoptosis and cell cycle arrest in lung cancer cells without TP53 mutation via p53 signalling pathway when stimulated with platelets.